Therapy Areas: Vaccines
14 November 2018 - AstraZeneca Plc (LSE:AZN), a global, science-led biopharmaceutical company, announced on Tuesday an agreement to sell US rights to Synagis (palivizumab), used for the prevention of ...
14 November 2018 - Agenus Inc (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, and adoptive cell therapies, announced yesterday that it has ...
13 November 2018 - - Analysts at UK-based technology research and advisory company Technavio  forecast the global cervical cancer diagnostic testing market to grow at a CAGR of over 6% durin...
9 November 2018 - - US-based biopharmaceutical company Sensei Biotherapeutics, Inc will highlight clinical and immunological data from the Phase 1 clinical trial of SNS-301 in a poster presentation at...
9 November 2018 - - French clinical stage biotech company Enyo Pharma has completed its phase Ib clinical trial evaluating the safety, pharmacokinetics and pharmacodynamics of its FXR agonist compound...
9 November 2018 - Immunicum AB (STO:IMMU), a biopharmaceutical company developing therapeutic cancer vaccines, on Thursday reported that at the Extraordinary General Meeting, held on 8 November 2018, ...
Related Headlines